{"id":"https://openalex.org/W1963965635","doi":"https://doi.org/10.1002/bdd.2510120204","title":"Distribution of oral nimesulide in female genital tissues","display_name":"Distribution of oral nimesulide in female genital tissues","publication_year":1991,"publication_date":"1991-03-01","ids":{"openalex":"https://openalex.org/W1963965635","doi":"https://doi.org/10.1002/bdd.2510120204","mag":"1963965635","pmid":"https://pubmed.ncbi.nlm.nih.gov/2031992"},"language":"en","primary_location":{"id":"doi:10.1002/bdd.2510120204","doi":"https://doi.org/10.1002/bdd.2510120204","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bdd.2510120204","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & Drug Disposition","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006827422","display_name":"MARTTI O. PULKKINEN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Martti O. Pulkkinen","raw_affiliation_strings":["Department of Obstetrics and Gynaecology, University of Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynaecology, University of Turku, Finland","institution_ids":["https://openalex.org/I155660961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049236565","display_name":"Maarit Vuento","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Maarit Vuento","raw_affiliation_strings":["Department of Obstetrics and Gynaecology, University of Turku, SF-20520 Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynaecology, University of Turku, SF-20520 Turku, Finland","institution_ids":["https://openalex.org/I155660961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082605576","display_name":"Alberto Macciocchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114493","display_name":"Helsinn (Switzerland)","ror":"https://ror.org/01kdzkq48","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210114493"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alberto Macciocchi","raw_affiliation_strings":["Product Development Department, Helsinn SA, Chiasso, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Development Department, Helsinn SA, Chiasso, Switzerland","institution_ids":["https://openalex.org/I4210114493"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108382555","display_name":"Tlziana Monti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114493","display_name":"Helsinn (Switzerland)","ror":"https://ror.org/01kdzkq48","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210114493"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Tlziana Monti","raw_affiliation_strings":["Product Development Department, Helsinn SA, Chiasso, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Development Department, Helsinn SA, Chiasso, Switzerland","institution_ids":["https://openalex.org/I4210114493"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5006827422"],"corresponding_institution_ids":["https://openalex.org/I155660961"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":1.1747,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.74888529,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"2","first_page":"113","last_page":"117"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.5609999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.5609999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.210099995136261,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.023900000378489494,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nimesulide","display_name":"nimesulide","score":1.0},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.8539999723434448},{"id":"https://openalex.org/keywords/uterus","display_name":"uterus","score":0.984000027179718},{"id":"https://openalex.org/keywords/cervix","display_name":"uterine cervix","score":0.9399999976158142},{"id":"https://openalex.org/keywords/fallopian-tube","display_name":"oviduct","score":0.9549999833106995},{"id":"https://openalex.org/keywords/ovary","display_name":"ovary","score":0.8650000095367432},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.5220000147819519},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.5839999914169312},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9160000085830688},{"id":"https://openalex.org/keywords/dysmenorrhea","display_name":"dysmenorrhea","score":0.8370000123977661},{"id":"https://openalex.org/keywords/hysterectomy","display_name":"hysterectomy","score":0.5889999866485596},{"id":"https://openalex.org/keywords/salpingo-oophorectomy","display_name":"salpingo-oophorectomy","score":0.9200000166893005},{"id":"https://openalex.org/keywords/uterine-fibroids","display_name":"uterine fibroids","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C2777570176","wikidata":"https://www.wikidata.org/wiki/Q20994","display_name":"Nimesulide","level":2,"score":0.9838322401046753},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.763084888458252},{"id":"https://openalex.org/C2779066055","wikidata":"https://www.wikidata.org/wiki/Q9612","display_name":"Uterus","level":2,"score":0.6182520985603333},{"id":"https://openalex.org/C2777740455","wikidata":"https://www.wikidata.org/wiki/Q666412","display_name":"Cervix","level":3,"score":0.5265631675720215},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.4706662893295288},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46352913975715637},{"id":"https://openalex.org/C2776391266","wikidata":"https://www.wikidata.org/wiki/Q9612","display_name":"Fundus (uterus)","level":2,"score":0.46207195520401},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45600780844688416},{"id":"https://openalex.org/C2777129507","wikidata":"https://www.wikidata.org/wiki/Q36857","display_name":"Oviduct","level":2,"score":0.4538307785987854},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4526422619819641},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4506644010543823},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.44568973779678345},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3853062093257904},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.30338844656944275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3013514280319214},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2069673240184784},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.08585771918296814},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005836","descriptor_name":"Genitalia, Female","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/bdd.2510120204","doi":"https://doi.org/10.1002/bdd.2510120204","is_oa":false,"landing_page_url":"https://doi.org/10.1002/bdd.2510120204","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & Drug Disposition","raw_type":"journal-article"},{"id":"pmid:2031992","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2031992","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & drug disposition","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1989115829","https://openalex.org/W2008209470","https://openalex.org/W2009007527","https://openalex.org/W2053419780","https://openalex.org/W2066191859","https://openalex.org/W2401029064","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W7221243682","https://openalex.org/W2095295711","https://openalex.org/W2037247402","https://openalex.org/W1971032613","https://openalex.org/W2408027533","https://openalex.org/W2354997491","https://openalex.org/W2341553906","https://openalex.org/W1972869964","https://openalex.org/W2042344701","https://openalex.org/W2281036158"],"abstract_inverted_index":{"Nimesulide":[0,92,151],"is":[1],"a":[2,42],"non-steroidal":[3],"anti-inflammatory":[4],"agent":[5],"which":[6],"has":[7],"proved":[8],"to":[9,35,53,58,138,147],"be":[10],"effective":[11],"in":[12,16,26,94,155],"reducing":[13],"menstrual":[14],"discomfort":[15],"dysmenorrhoeaic":[17],"women.":[18],"To":[19],"determine":[20],"the":[21,27,95,107,156],"concentrations":[22,124,144],"of":[23,46,73],"this":[24],"drug":[25,133],"uterus":[28],"(fundus,":[29],"cervix),":[30],"oviduct,":[31],"and":[32,34,63,78,129,142],"ovaries":[33],"correlate":[36],"these":[37],"findings":[38,79],"with":[39,81],"plasma":[40,82,143],"concentrations,":[41],"single":[43],"oral":[44],"dose":[45],"100":[47],"mg":[48],"nimesulide":[49,74],"was":[50,98,116,152],"administered":[51],"1":[52],"6":[54,130],"h":[55,101,131],"before":[56],"surgery":[57],"12":[59],"women":[60],"undergoing":[61,87],"hysterectomy":[62],"salpingo-oophorectomy,":[64],"mainly":[65],"for":[66],"fibroids.":[67],"Tissue":[68],"samples":[69],"were":[70],"taken,":[71],"concentration":[72,93],"measured":[75],"by":[76],"HPLC,":[77],"compared":[80],"concentrations.":[83],"One":[84],"patient":[85],"not":[86],"treatment":[88],"served":[89],"as":[90,104],"control.":[91],"tissues":[96,157],"studied":[97],"highest":[99,112],"3":[100],"after":[102,132],"administration,":[103],"expected":[105],"from":[106,136,145],"drug's":[108],"pharmacokinetic":[109],"profile.":[110],"The":[111],"tissue/plasma":[113],"ratio":[114],"(0.5)":[115],"also":[117],"found":[118],"at":[119,125],"that":[120],"time.":[121],"Average":[122],"tissue":[123],"1,":[126],"2,":[127],"3,":[128],"intake":[134],"ranged":[135],"0.3":[137],"1.8":[139],"micrograms":[140,149],"g-1,":[141],"2.6":[146],"4.1":[148],"ml-1.":[150],"evenly":[153],"distributed":[154],"studied.":[158]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}